CD8A and neoplasm: Together, these data suggest that in the context of a strong tumor antigen-specific CD8+ T cell response and PD-L1 blockade, IFN-γ-insensitive tumor cells have a selective growth advantage out of a mixture with WT tumor cells, allowing escape which equates to therapeutic resistance.